28 Approved Peptides with MW < 2000
TERLIPRESSIN
Approved in 2022 (PDB entries)
DIFELIKEFALIN
Approved in 2021 (PDB entries)
VOCLOSPORIN
Approved in 2021 (PDB entries)
SETMELANOTIDE
Approved in 2020 (PDB entries)
AFAMELANOTIDE
Approved in 2019 (PDB entries)
BREMELANOTIDE
Approved in 2019 (PDB entries)
L-GLUTAMINE
Approved in 2017 (PDB entries)
ETELCALCETIDE
Approved in 2017 (PDB entries)
PLECANATIDE
Approved in 2017 (PDB entries)
ANGIOTENSIN II
Approved in 2017 (PDB entries)
VASOPRESSIN
(Re)approved in 2014 (PDB entries)
LINACLOTIDE
Approved in 2012 (PDB entries)
TRIPTORELIN
Approved in 2000 (PDB entries)
EPTIFIBATIDE
Approved in 1998 (PDB entries)
NAFARELIN
Approved in 1990 (PDB entries)
GOSERELIN
Approved in 1989 (PDB entries)
OCTREOTIDE
Approved in 1988 (PDB entries)
LEUPROLIDE
Approved in 1985 (PDB entries)
CYCLOSPORINE
Approved in 1983 (PDB entries)
GLUTATHIONE DISULFIDE
Approved in 1981 (PDB entry 1YKC)
OXYTOCIN
Approved in 1980 (PDB entries)
DESMOPRESSIN
Approved in 1978 (PDB entries)
SINCALIDE
Approved in 1976 (PDB entries)
PENTAGASTRIN
DISCONTINUED (Approved in 1974) (PDB entries)
GRAMICIDIN
Approved in 1968 (PDB entries)
TYROSINE
DISCONTINUED (PDB entry 4QBT)
LYPRESSIN
DISCONTINUED (PDB entries)
SARALASIN
DISCONTINUED (PDB entries)
|